Erythromycin
Pricing Report NDC 0574-4024-50

Current NADAC: $6.83399 per GM · Effective Sep 23, 2026 · Est. package price $341.70 (50 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The current wholesale acquisition cost for Erythromycin (NDC 0574-4024-50) is $6.83399 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a provided by Padagis Us Llc, this medication is distributed in a 50 TUBE in 1 CARTON / 1 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.83399
Per GM

Effective Date
Sep 23, 2026
Billable Units
50 GM
Estimated Package Price
$341.70
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
50 TUBE in 1 CARTON / 1 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2014, the NADAC wholesale price for (NDC ) has moved within a range of $1.75864 to $7.64257 per GM. Over this 12 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.7586 - $3.6977
Market Volatility
110.26% Variance
Latest Trend
0.26%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $2.82657 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Sep 23, 2026 $6.83399 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Aug 19, 2026 $2.83387 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Aug 19, 2026 $6.71597 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Jul 22, 2026 $2.82882 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Jun 17, 2026 $2.86451 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
May 20, 2026 $2.86414 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Apr 22, 2026 $2.86140 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Apr 22, 2026 $6.32544 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Apr 22, 2026 $6.32544 GMC/I - Chain or Independent PharmacyCode 4, 5G - Generic
Mar 18, 2026 $2.86563 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic
Mar 18, 2026 $6.32544 GMC/I - Chain or Independent PharmacyCode 1, 5G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026